BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

23 related articles for article (PubMed ID: 38513960)

  • 1. Weekly assessment of volumetric and dosimetric changes during volumetric modulated arc therapy of locally advanced head and neck carcinoma: Implications for adaptive radiation therapy-A prospective study.
    Sreejeev AT; Joseph D; Krishnan AS; Pasricha R; Gupta S; Ahuja R; Sharma N; Sikdar D; Raut S; Sasi A; Gupta M
    Head Neck; 2024 Jul; 46(7):1547-1556. PubMed ID: 38436506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Robustness analysis of dynamic trajectory radiotherapy and volumetric modulated arc therapy plans for head and neck cancer.
    Loebner HA; Bertholet J; Mackeprang PH; Volken W; Elicin O; Mueller S; Guyer G; Aebersold DM; Stampanoni MFM; Fix MK; Manser P
    Phys Imaging Radiat Oncol; 2024 Apr; 30():100586. PubMed ID: 38808098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organ-at-risk sparing with dynamic trajectory radiotherapy for head and neck cancer: comparison with volumetric arc therapy on a publicly available library of cases.
    Bertholet J; Mackeprang PH; Mueller S; Guyer G; Loebner HA; Wyss Y; Frei D; Volken W; Elicin O; Aebersold DM; Fix MK; Manser P
    Radiat Oncol; 2022 Jul; 17(1):122. PubMed ID: 35841098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetrically motivated beam-angle optimization for non-coplanar arc radiotherapy with and without dynamic collimator rotation.
    Bertholet J; Zhu C; Guyer G; Mueller S; Volken W; Mackeprang PH; Loebner HA; Stampanoni MFM; Aebersold DM; Fix MK; Manser P
    Med Phys; 2024 Feb; 51(2):1326-1339. PubMed ID: 38131614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multivariable normal tissue complication probability model-based treatment plan optimization for grade 2-4 dysphagia and tube feeding dependence in head and neck radiotherapy.
    Kierkels RGJ; Wopken K; Visser R; Korevaar EW; van der Schaaf A; Bijl HP; Langendijk JA
    Radiother Oncol; 2016 Dec; 121(3):374-380. PubMed ID: 27614681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Volumetric modulated arc therapy (VMAT) and simultaneous integrated boost in head-and-neck cancer: is there a place for critical swallowing structures dose sparing?
    Cilla S; Deodato F; Macchia G; Digesù C; Ianiro A; Piermattei A; Valentini V; Morganti AG
    Br J Radiol; 2016; 89(1059):20150764. PubMed ID: 26728543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences between planned and delivered dose for head and neck cancer, and their consequences for normal tissue complication probability and treatment adaptation.
    Heukelom J; Kantor ME; Mohamed ASR; Elhalawani H; Kocak-Uzel E; Lin T; Yang J; Aristophanous M; Rasch CR; Fuller CD; Sonke JJ
    Radiother Oncol; 2020 Jan; 142():100-106. PubMed ID: 31431381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organs-at-risk dose and normal tissue complication probability with dynamic trajectory radiotherapy (DTRT) for head and neck cancer.
    Bertholet J; Mackeprang PH; Loebner HA; Mueller S; Guyer G; Frei D; Volken W; Elicin O; Aebersold DM; Fix MK; Manser P
    Radiother Oncol; 2024 Jun; 195():110237. PubMed ID: 38513960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IMRT for head and neck cancer: reducing xerostomia and dysphagia.
    Wang X; Eisbruch A
    J Radiat Res; 2016 Aug; 57 Suppl 1(Suppl 1):i69-i75. PubMed ID: 27538846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between plan quality improvements and reduced acute dysphagia and xerostomia in the definitive treatment of oropharyngeal squamous cell carcinoma.
    Cui T; Ward MC; Joshi NP; Woody NM; Murray EJ; Potter J; Dorfmeyer AA; Greskovich JF; Koyfman SA; Xia P
    Head Neck; 2019 Apr; 41(4):1096-1103. PubMed ID: 30702180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Proton therapy for head and neck squamous cell carcinomas: From physics to clinic].
    Beddok A; Vela A; Calugaru V; Tessonnier T; Kubes J; Dutheil P; Gérard A; Vidal M; Goudjil F; Florescu C; Kammerer E; Bénézery K; Hérault J; Bourhis J; Thariat J;
    Cancer Radiother; 2019 Sep; 23(5):439-448. PubMed ID: 31358445
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.